A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus

Summary

The purpose of this study is to evaluate the amount of tabalumab in the blood after it is given by two different injection methods - A traditional syringe or a spring loaded syringe for 12 weeks. Participants may continue to receive study drug for up to 52 weeks.

Timeline

Start

2014-01

Primary completion

2014-10

Completion

2015-11

Drugs

Indications